APO Research
Talk to an analyst

APO RESEARCH · REPORT

Beta-2 Microglobulin (B2M)

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Beta-2 Microglobulin (B2M) Market Outlook and Growth Opportunities 2026

2 January 2026195 pages

Choose your research edition.

Industry ResearchBeta-2 Microglobulin (B2M) Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal Beta-2 Microglobulin (B2M) Industry Growth and Trends Forecast to 203294 pages · $3,450 USDMarket StructureGlobal Beta-2 Microglobulin (B2M) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032187 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Beta-2 Microglobulin (B2M) Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Beta-2 Microglobulin (B2M) Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Beta-2 Microglobulin (B2M) market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Beta-2 Microglobulin (B2M) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Beta-2 Microglobulin (B2M) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Beta-2 Microglobulin (B2M) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Beta-2 Microglobulin (B2M) market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Beta-2 Microglobulin (B2M) market include Wuhan Huamei Biotech Co, Fosun Pharmaceutical, Tosoh, Prospec-Tany Technogene Ltd, Lee Biosolutions, Bio-Rad and Abcam, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Beta-2 Microglobulin (B2M) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Beta-2 Microglobulin (B2M) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Beta-2 Microglobulin (B2M) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Beta-2 Microglobulin (B2M) market size, projected growth trends, production technologies, key applications, and end-use industries.

Beta-2 Microglobulin (B2M) Segment by Company

Wuhan Huamei Biotech Co

Fosun Pharmaceutical

Tosoh

Prospec-Tany Technogene Ltd

Lee Biosolutions

Bio-Rad

Abcam

Beta-2 Microglobulin (B2M) Segment by Type

Purity,≥98%

Purity,≥95%

Others

Beta-2 Microglobulin (B2M) Segment by Application

ELISA

Flow Cytometry

Western Blotting

Others

Beta-2 Microglobulin (B2M) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Beta-2 Microglobulin (B2M) status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Beta-2 Microglobulin (B2M) market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Beta-2 Microglobulin (B2M) significant trends, drivers, influence factors in global and regions.

6. To analyze Beta-2 Microglobulin (B2M) competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Beta-2 Microglobulin (B2M) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Beta-2 Microglobulin (B2M) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Beta-2 Microglobulin (B2M).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Beta-2 Microglobulin (B2M) market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Beta-2 Microglobulin (B2M) industry.

Chapter 3: Detailed analysis of Beta-2 Microglobulin (B2M) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Beta-2 Microglobulin (B2M) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Beta-2 Microglobulin (B2M) in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Beta-2 Microglobulin (B2M) Industry Trends Table 2. Beta-2 Microglobulin (B2M) Industry Drivers Table 3. Beta-2 Microglobulin (B2M) Industry Opportunities and Challenges Table 4. Beta-2 Microglobulin (B2M) Industry Restraints Table 5. Global Beta-2 Microglobulin (B2M) Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Beta-2 Microglobulin (B2M) Revenue Share by Company (2021-2026) Table 7. Global Beta-2 Microglobulin (B2M) Sales Volume by Company (g) & (2021-2026) Table 8. Global Beta-2 Microglobulin (B2M) Sales Volume Share by Company (2021-2026) Table 9. Global Beta-2 Microglobulin (B2M) Average Price (US$/mg) of Company (2021-2026) Table 10. Global Beta-2 Microglobulin (B2M) Company Ranking, (2024-2026) & (USD Million) Table 11. Global Beta-2 Microglobulin (B2M) Key Company Manufacturing Base & Headquarters Table 12. Global Beta-2 Microglobulin (B2M) Company, Product Type & Application Table 13. Global Beta-2 Microglobulin (B2M) Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Beta-2 Microglobulin (B2M) by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Purity,≥98% Table 18. Significant Companies of Purity,≥95% Table 19. Significant Companies of Others Table 20. Global Beta-2 Microglobulin (B2M) Sales Volume by Type 2021 VS 2025 VS 2032 (g) Table 21. Global Beta-2 Microglobulin (B2M) Sales Volume by Type (2021-2026) & (g) Table 22. Global Beta-2 Microglobulin (B2M) Sales Volume by Type (2027-2032) & (g) Table 23. Global Beta-2 Microglobulin (B2M) Sales Volume Share by Type (2021-2026) Table 24. Global Beta-2 Microglobulin (B2M) Sales Volume Share by Type (2027-2032) Table 25. Global Beta-2 Microglobulin (B2M) Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global Beta-2 Microglobulin (B2M) Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global Beta-2 Microglobulin (B2M) Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global Beta-2 Microglobulin (B2M) Sales Value Share by Type (2021-2026) Table 29. Global Beta-2 Microglobulin (B2M) Sales Value Share by Type (2027-2032) Table 30. Significant Companies of ELISA Table 31. Significant Companies of Flow Cytometry Table 32. Significant Companies of Western Blotting Table 33. Significant Companies of Others Table 34. Global Beta-2 Microglobulin (B2M) Sales Volume by Application 2021 VS 2025 VS 2032 (g) Table 35. Global Beta-2 Microglobulin (B2M) Sales Volume by Application (2021-2026) & (g) Table 36. Global Beta-2 Microglobulin (B2M) Sales Volume by Application (2027-2032) & (g) Table 37. Global Beta-2 Microglobulin (B2M) Sales Volume Share by Application (2021-2026) Table 38. Global Beta-2 Microglobulin (B2M) Sales Volume Share by Application (2027-2032) Table 39. Global Beta-2 Microglobulin (B2M) Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Beta-2 Microglobulin (B2M) Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global Beta-2 Microglobulin (B2M) Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global Beta-2 Microglobulin (B2M) Sales Value Share by Application (2021-2026) Table 43. Global Beta-2 Microglobulin (B2M) Sales Value Share by Application (2027-2032) Table 44. Global Beta-2 Microglobulin (B2M) Sales by Region: 2021 VS 2025 VS 2032 (g) Table 45. Global Beta-2 Microglobulin (B2M) Sales by Region (2021-2026) & (g) Table 46. Global Beta-2 Microglobulin (B2M) Sales Market Share by Region (2021-2026) Table 47. Global Beta-2 Microglobulin (B2M) Sales by Region (2027-2032) & (g) Table 48. Global Beta-2 Microglobulin (B2M) Sales Market Share by Region (2027-2032) Table 49. Global Beta-2 Microglobulin (B2M) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Beta-2 Microglobulin (B2M) Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global Beta-2 Microglobulin (B2M) Sales Value Share by Region (2021-2026) Table 52. Global Beta-2 Microglobulin (B2M) Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global Beta-2 Microglobulin (B2M) Sales Value Share by Region (2027-2032) Table 54. Global Beta-2 Microglobulin (B2M) Market Average Price (US$/mg) by Region (2021-2026) Table 55. Global Beta-2 Microglobulin (B2M) Market Average Price (US$/mg) by Region (2027-2032) Table 56. Global Beta-2 Microglobulin (B2M) Sales by Country: 2021 VS 2025 VS 2032 (g) Table 57. Global Beta-2 Microglobulin (B2M) Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global Beta-2 Microglobulin (B2M) Sales by Country (2021-2026) & (g) Table 59. Global Beta-2 Microglobulin (B2M) Sales Market Share by Country (2021-2026) Table 60. Global Beta-2 Microglobulin (B2M) Sales by Country (2027-2032) & (g) Table 61. Global Beta-2 Microglobulin (B2M) Sales Market Share by Country (2027-2032) Table 62. Global Beta-2 Microglobulin (B2M) Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global Beta-2 Microglobulin (B2M) Sales Value Market Share by Country (2021-2026) Table 64. Global Beta-2 Microglobulin (B2M) Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global Beta-2 Microglobulin (B2M) Sales Value Market Share by Country (2027-2032) Table 66. Wuhan Huamei Biotech Co Company Information Table 67. Wuhan Huamei Biotech Co Business Overview Table 68. Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Sales (g), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 69. Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Product Portfolio Table 70. Wuhan Huamei Biotech Co Recent Development Table 71. Fosun Pharmaceutical Company Information Table 72. Fosun Pharmaceutical Business Overview Table 73. Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Sales (g), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 74. Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Product Portfolio Table 75. Fosun Pharmaceutical Recent Development Table 76. Tosoh Company Information Table 77. Tosoh Business Overview Table 78. Tosoh Beta-2 Microglobulin (B2M) Sales (g), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 79. Tosoh Beta-2 Microglobulin (B2M) Product Portfolio Table 80. Tosoh Recent Development Table 81. Prospec-Tany Technogene Ltd Company Information Table 82. Prospec-Tany Technogene Ltd Business Overview Table 83. Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Sales (g), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 84. Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Product Portfolio Table 85. Prospec-Tany Technogene Ltd Recent Development Table 86. Lee Biosolutions Company Information Table 87. Lee Biosolutions Business Overview Table 88. Lee Biosolutions Beta-2 Microglobulin (B2M) Sales (g), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 89. Lee Biosolutions Beta-2 Microglobulin (B2M) Product Portfolio Table 90. Lee Biosolutions Recent Development Table 91. Bio-Rad Company Information Table 92. Bio-Rad Business Overview Table 93. Bio-Rad Beta-2 Microglobulin (B2M) Sales (g), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 94. Bio-Rad Beta-2 Microglobulin (B2M) Product Portfolio Table 95. Bio-Rad Recent Development Table 96. Abcam Company Information Table 97. Abcam Business Overview Table 98. Abcam Beta-2 Microglobulin (B2M) Sales (g), Value (US$ Million), Price (US$/mg) and Gross Margin (2021-2026) Table 99. Abcam Beta-2 Microglobulin (B2M) Product Portfolio Table 100. Abcam Recent Development Table 101. Key Raw Materials Table 102. Raw Materials Key Suppliers Table 103. Beta-2 Microglobulin (B2M) Distributors List Table 104. Beta-2 Microglobulin (B2M) Customers List Table 105. Research Programs/Design for This Report Table 106. Authors List of This Report Table 107. Secondary Sources Table 108. Primary Sources List of Figures Figure 1. Beta-2 Microglobulin (B2M) Product Image Figure 2. Global Beta-2 Microglobulin (B2M) Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Beta-2 Microglobulin (B2M) Sales Value (2021-2032) & (US$ Million) Figure 4. Global Beta-2 Microglobulin (B2M) Sales (2021-2032) & (g) Figure 5. Global Beta-2 Microglobulin (B2M) Sales Average Price (US$/mg) & (2021-2032) Figure 6. Global Beta-2 Microglobulin (B2M) Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Purity,≥98% Image Figure 10. Purity,≥95% Image Figure 11. Others Image Figure 12. Global Beta-2 Microglobulin (B2M) Sales Volume by Type (2021 VS 2025 VS 2032) & (g) Figure 13. Global Beta-2 Microglobulin (B2M) Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global Beta-2 Microglobulin (B2M) Sales Volume Share by Type (2021-2032) Figure 15. Global Beta-2 Microglobulin (B2M) Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global Beta-2 Microglobulin (B2M) Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global Beta-2 Microglobulin (B2M) Sales Value Share by Type (2021-2032) Figure 18. ELISA Image Figure 19. Flow Cytometry Image Figure 20. Western Blotting Image Figure 21. Others Image Figure 22. Global Beta-2 Microglobulin (B2M) Sales Volume by Application (2021 VS 2025 VS 2032) & (g) Figure 23. Global Beta-2 Microglobulin (B2M) Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global Beta-2 Microglobulin (B2M) Sales Volume Share by Application (2021-2032) Figure 25. Global Beta-2 Microglobulin (B2M) Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global Beta-2 Microglobulin (B2M) Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global Beta-2 Microglobulin (B2M) Sales Value Share by Application (2021-2032) Figure 28. Global Beta-2 Microglobulin (B2M) Sales by Region: 2021 VS 2025 VS 2032 (g) Figure 29. Global Beta-2 Microglobulin (B2M) Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global Beta-2 Microglobulin (B2M) Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global Beta-2 Microglobulin (B2M) Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America Beta-2 Microglobulin (B2M) Sales Value (2021-2032) & (US$ Million) Figure 33. North America Beta-2 Microglobulin (B2M) Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe Beta-2 Microglobulin (B2M) Sales Value (2021-2032) & (US$ Million) Figure 35. Europe Beta-2 Microglobulin (B2M) Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific Beta-2 Microglobulin (B2M) Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific Beta-2 Microglobulin (B2M) Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America Beta-2 Microglobulin (B2M) Sales Value (2021-2032) & (US$ Million) Figure 39. South America Beta-2 Microglobulin (B2M) Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa Beta-2 Microglobulin (B2M) Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa Beta-2 Microglobulin (B2M) Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. Beta-2 Microglobulin (B2M) Value Chain Figure 127. Manufacturing Cost Structure Figure 128. Beta-2 Microglobulin (B2M) Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • Purity,≥98%
  • Purity,≥95%
  • Others
Applications
  • ELISA
  • Flow Cytometry
  • Western Blotting
  • Others
Companies covered
  • Wuhan Huamei Biotech Co
  • Fosun Pharmaceutical
  • Tosoh
  • Prospec-Tany Technogene Ltd
  • Lee Biosolutions
  • Bio-Rad
  • Abcam

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Beta-2 Microglobulin (B2M) Sales Value (2021-2032)
  4. 1.2.2 Global Beta-2 Microglobulin (B2M) Sales Volume (2021-2032)
  5. 1.2.3 Global Beta-2 Microglobulin (B2M) Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Beta-2 Microglobulin (B2M) Market Dynamics
  1. 2.1 Beta-2 Microglobulin (B2M) Industry Trends
  2. 2.2 Beta-2 Microglobulin (B2M) Industry Drivers
  3. 2.3 Beta-2 Microglobulin (B2M) Industry Opportunities and Challenges
  4. 2.4 Beta-2 Microglobulin (B2M) Industry Restraints
3 Beta-2 Microglobulin (B2M) Market by Company
  1. 3.1 Global Beta-2 Microglobulin (B2M) Company Revenue Ranking in 2025
  2. 3.2 Global Beta-2 Microglobulin (B2M) Revenue by Company (2021-2026)
  3. 3.3 Global Beta-2 Microglobulin (B2M) Sales Volume by Company (2021-2026)
  4. 3.4 Global Beta-2 Microglobulin (B2M) Average Price by Company (2021-2026)
  5. 3.5 Global Beta-2 Microglobulin (B2M) Company Ranking (2024-2026)
  6. 3.6 Global Beta-2 Microglobulin (B2M) Company Manufacturing Base and Headquarters
  7. 3.7 Global Beta-2 Microglobulin (B2M) Company Product Type and Application
  8. 3.8 Global Beta-2 Microglobulin (B2M) Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Beta-2 Microglobulin (B2M) Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Beta-2 Microglobulin (B2M) Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Beta-2 Microglobulin (B2M) Market by Type
  1. 4.1 Beta-2 Microglobulin (B2M) Type Introduction
  2. 4.1.1 Purity,≥98%
  3. 4.1.2 Purity,≥95%
  4. 4.1.3 Others
  5. 4.2 Global Beta-2 Microglobulin (B2M) Sales Volume by Type
  6. 4.2.1 Global Beta-2 Microglobulin (B2M) Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Beta-2 Microglobulin (B2M) Sales Volume by Type (2021-2032)
  8. 4.2.3 Global Beta-2 Microglobulin (B2M) Sales Volume Share by Type (2021-2032)
  9. 4.3 Global Beta-2 Microglobulin (B2M) Sales Value by Type
  10. 4.3.1 Global Beta-2 Microglobulin (B2M) Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Beta-2 Microglobulin (B2M) Sales Value by Type (2021-2032)
  12. 4.3.3 Global Beta-2 Microglobulin (B2M) Sales Value Share by Type (2021-2032)
5 Beta-2 Microglobulin (B2M) Market by Application
  1. 5.1 Beta-2 Microglobulin (B2M) Application Introduction
  2. 5.1.1 ELISA
  3. 5.1.2 Flow Cytometry
  4. 5.1.3 Western Blotting
  5. 5.1.4 Others
  6. 5.2 Global Beta-2 Microglobulin (B2M) Sales Volume by Application
  7. 5.2.1 Global Beta-2 Microglobulin (B2M) Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Beta-2 Microglobulin (B2M) Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Beta-2 Microglobulin (B2M) Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Beta-2 Microglobulin (B2M) Sales Value by Application
  11. 5.3.1 Global Beta-2 Microglobulin (B2M) Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Beta-2 Microglobulin (B2M) Sales Value by Application (2021-2032)
  13. 5.3.3 Global Beta-2 Microglobulin (B2M) Sales Value Share by Application (2021-2032)
6 Beta-2 Microglobulin (B2M) Regional Sales and Value Analysis
  1. 6.1 Global Beta-2 Microglobulin (B2M) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Beta-2 Microglobulin (B2M) Sales by Region (2021-2032)
  3. 6.2.1 Global Beta-2 Microglobulin (B2M) Sales by Region: 2021-2026
  4. 6.2.2 Global Beta-2 Microglobulin (B2M) Sales by Region (2027-2032)
  5. 6.3 Global Beta-2 Microglobulin (B2M) Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Beta-2 Microglobulin (B2M) Sales Value by Region (2021-2032)
  7. 6.4.1 Global Beta-2 Microglobulin (B2M) Sales Value by Region: 2021-2026
  8. 6.4.2 Global Beta-2 Microglobulin (B2M) Sales Value by Region (2027-2032)
  9. 6.5 Global Beta-2 Microglobulin (B2M) Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Beta-2 Microglobulin (B2M) Sales Value (2021-2032)
  12. 6.6.2 North America Beta-2 Microglobulin (B2M) Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Beta-2 Microglobulin (B2M) Sales Value (2021-2032)
  15. 6.7.2 Europe Beta-2 Microglobulin (B2M) Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Beta-2 Microglobulin (B2M) Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Beta-2 Microglobulin (B2M) Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Beta-2 Microglobulin (B2M) Sales Value (2021-2032)
  21. 6.9.2 South America Beta-2 Microglobulin (B2M) Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Beta-2 Microglobulin (B2M) Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Beta-2 Microglobulin (B2M) Sales Value Share by Country, 2025 VS 2032
7 Beta-2 Microglobulin (B2M) Country-level Sales and Value Analysis
  1. 7.1 Global Beta-2 Microglobulin (B2M) Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Beta-2 Microglobulin (B2M) Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Beta-2 Microglobulin (B2M) Sales by Country (2021-2032)
  4. 7.3.1 Global Beta-2 Microglobulin (B2M) Sales by Country (2021-2026)
  5. 7.3.2 Global Beta-2 Microglobulin (B2M) Sales by Country (2027-2032)
  6. 7.4 Global Beta-2 Microglobulin (B2M) Sales Value by Country (2021-2032)
  7. 7.4.1 Global Beta-2 Microglobulin (B2M) Sales Value by Country (2021-2026)
  8. 7.4.2 Global Beta-2 Microglobulin (B2M) Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Beta-2 Microglobulin (B2M) Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Beta-2 Microglobulin (B2M) Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Beta-2 Microglobulin (B2M) Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Wuhan Huamei Biotech Co
  2. 8.1.1 Wuhan Huamei Biotech Co Company Information
  3. 8.1.2 Wuhan Huamei Biotech Co Business Overview
  4. 8.1.3 Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Wuhan Huamei Biotech Co Beta-2 Microglobulin (B2M) Product Portfolio
  6. 8.1.5 Wuhan Huamei Biotech Co Recent Developments
  7. 8.2 Fosun Pharmaceutical
  8. 8.2.1 Fosun Pharmaceutical Company Information
  9. 8.2.2 Fosun Pharmaceutical Business Overview
  10. 8.2.3 Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Fosun Pharmaceutical Beta-2 Microglobulin (B2M) Product Portfolio
  12. 8.2.5 Fosun Pharmaceutical Recent Developments
  13. 8.3 Tosoh
  14. 8.3.1 Tosoh Company Information
  15. 8.3.2 Tosoh Business Overview
  16. 8.3.3 Tosoh Beta-2 Microglobulin (B2M) Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Tosoh Beta-2 Microglobulin (B2M) Product Portfolio
  18. 8.3.5 Tosoh Recent Developments
  19. 8.4 Prospec-Tany Technogene Ltd
  20. 8.4.1 Prospec-Tany Technogene Ltd Company Information
  21. 8.4.2 Prospec-Tany Technogene Ltd Business Overview
  22. 8.4.3 Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Prospec-Tany Technogene Ltd Beta-2 Microglobulin (B2M) Product Portfolio
  24. 8.4.5 Prospec-Tany Technogene Ltd Recent Developments
  25. 8.5 Lee Biosolutions
  26. 8.5.1 Lee Biosolutions Company Information
  27. 8.5.2 Lee Biosolutions Business Overview
  28. 8.5.3 Lee Biosolutions Beta-2 Microglobulin (B2M) Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Lee Biosolutions Beta-2 Microglobulin (B2M) Product Portfolio
  30. 8.5.5 Lee Biosolutions Recent Developments
  31. 8.6 Bio-Rad
  32. 8.6.1 Bio-Rad Company Information
  33. 8.6.2 Bio-Rad Business Overview
  34. 8.6.3 Bio-Rad Beta-2 Microglobulin (B2M) Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Bio-Rad Beta-2 Microglobulin (B2M) Product Portfolio
  36. 8.6.5 Bio-Rad Recent Developments
  37. 8.7 Abcam
  38. 8.7.1 Abcam Company Information
  39. 8.7.2 Abcam Business Overview
  40. 8.7.3 Abcam Beta-2 Microglobulin (B2M) Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Abcam Beta-2 Microglobulin (B2M) Product Portfolio
  42. 8.7.5 Abcam Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Beta-2 Microglobulin (B2M) Value Chain Analysis
  2. 9.1.1 Beta-2 Microglobulin (B2M) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Beta-2 Microglobulin (B2M) Sales Mode & Process
  6. 9.2 Beta-2 Microglobulin (B2M) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Beta-2 Microglobulin (B2M) Distributors
  9. 9.2.3 Beta-2 Microglobulin (B2M) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst